BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16885353)

  • 1. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.
    Sterling JA; Oyajobi BO; Grubbs B; Padalecki SS; Munoz SA; Gupta A; Story B; Zhao M; Mundy GR
    Cancer Res; 2006 Aug; 66(15):7548-53. PubMed ID: 16885353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.
    Johnson RW; Nguyen MP; Padalecki SS; Grubbs BG; Merkel AR; Oyajobi BO; Matrisian LM; Mundy GR; Sterling JA
    Cancer Res; 2011 Feb; 71(3):822-31. PubMed ID: 21189326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
    Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo.
    Guise TA; Yin JJ; Thomas RJ; Dallas M; Cui Y; Gillespie MT
    Bone; 2002 May; 30(5):670-6. PubMed ID: 11996903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
    Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
    J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Thioguanine inhibition of parathyroid hormone-related protein expression is mediated by GLI2.
    Johnson RW; Merkel AR; Danilin S; Nguyen MP; Mundy GR; Sterling JA
    Anticancer Res; 2011 Sep; 31(9):2705-12. PubMed ID: 21868511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.
    Fisher JL; Thomas-Mudge RJ; Elliott J; Hards DK; Sims NA; Slavin J; Martin TJ; Gillespie MT
    Cancer Res; 2006 Apr; 66(7):3620-8. PubMed ID: 16585187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of parathyroid hormone-related peptide by estradiol: effect on tumor growth and metastasis in vitro and in vivo.
    Rabbani SA; Khalili P; Arakelian A; Pizzi H; Chen G; Goltzman D
    Endocrinology; 2005 Jul; 146(7):2885-94. PubMed ID: 15831570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.
    Gilmore JL; Scott JA; Bouizar Z; Robling A; Pitfield SE; Riese DJ; Foley J
    Breast Cancer Res Treat; 2008 Aug; 110(3):493-505. PubMed ID: 17882547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
    Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
    J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction.
    Son J; Lee JH; Kim HN; Ha H; Lee ZH
    Biochem Biophys Res Commun; 2010 Jul; 398(2):309-14. PubMed ID: 20599715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
    Isowa S; Shimo T; Ibaragi S; Kurio N; Okui T; Matsubara K; Hassan NM; Kishimoto K; Sasaki A
    Anticancer Res; 2010 Jul; 30(7):2755-67. PubMed ID: 20683010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
    Saito H; Tsunenari T; Onuma E; Sato K; Ogata E; Yamada-Okabe H
    Anticancer Res; 2005; 25(6B):3817-23. PubMed ID: 16309168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone-related peptide regulates matrix metalloproteinase-13 gene expression in bone metastatic breast cancer cells.
    Ibaragi S; Shimo T; Iwamoto M; Hassan NM; Kodama S; Isowa S; Sasaki A
    Anticancer Res; 2010 Dec; 30(12):5029-36. PubMed ID: 21187486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
    Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
    Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
    Kitazawa S; Kitazawa R
    J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism.
    Lindemann RK; Ballschmieter P; Nordheim A; Dittmer J
    J Biol Chem; 2001 Dec; 276(49):46661-70. PubMed ID: 11590145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo.
    Gallwitz WE; Guise TA; Mundy GR
    J Clin Invest; 2002 Nov; 110(10):1559-72. PubMed ID: 12438453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.